TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Västerås Medica AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
214
|
195 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
54
|
42 | |
| EBITDA |
54
|
42 | |
| Total assets |
78
|
59 | |
| Current assets |
78
|
59 | |
| Current liabilities |
26
|
13 | |
| Equity capital |
52
|
45 | |
| - share capital |
9
|
9 | |
| Employees (average) |
2
|
0
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
66.7%
|
76.3% | |
| Turnover per employee | 98 | ||
| Profit as a percentage of turnover |
25.2%
|
21.5% | |
| Return on assets (ROA) |
69.2%
|
71.2% | |
| Current ratio |
300%
|
453.8% | |
| Return on equity (ROE) |
103.8%
|
93.3% | |
| Change turnover |
18
|
-1 | |
| Change turnover % |
8%
|
9%
|
0% |
| Chg. No. of employees |
2
|
-2
|
0 |
| Chg. No. of employees % |
-100%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.